Literature DB >> 19148490

microRNA expression profile in undifferentiated gastric cancer.

Takeyasu Katada1, Hideyuki Ishiguro, Yoshiyuki Kuwabara, Masahiro Kimura, Akira Mitui, Yoichiro Mori, Ryo Ogawa, Koshiro Harata, Yoshitaka Fujii.   

Abstract

Prognosis of patients with undifferentiated gastric cancer is generally poor. The expression of various microRNAs (miRNAs) has not been comprehensively investigated in undifferentiated gastric cancer. Total RNA was extracted from the specimens of 42 undifferentiated gastric cancer tissues and paired normal gastric tissue. Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was performed for a set of 72 miRNAs. The expression of each miRNA relative to the internal control RNA was determined using the 2-DeltaCt method. The expression levels of 3 miRNAs (mir-34b, mir-34c and mir-128a) were significantly upregulated and those of 3 miRNAs (mir-128b, mir-129 and mir-148) were downregulated in undifferentiated gastric cancer tissue when compared with those of the paired normal tissues. The probability of survival was significantly lower in patients with high expression levels of mir-20b or 150. There was a correlation between mir-27a and lymph node metastasis. Our investigation provides a list of candidate miRNAs that may be associated with the prognosis in undifferentiated gastric cancer patients. Further study is warranted to identify the target genes of these miRNAs and their function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19148490

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  98 in total

1.  MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.

Authors:  Akao Zhu; Jiazeng Xia; Junbo Zuo; Shimao Jin; Hong Zhou; Lubin Yao; Hongyu Huang; Zhijun Han
Journal:  Med Oncol       Date:  2011-12-14       Impact factor: 3.064

2.  Identification of microRNAs associated with lymphangiogenesis in human gastric cancer.

Authors:  B Yang; C Jing; J Wang; X Guo; Y Chen; R Xu; L Peng; J Liu; L Li
Journal:  Clin Transl Oncol       Date:  2013-07-24       Impact factor: 3.405

3.  High-throughput functional microRNA profiling using recombinant AAV-based microRNA sensor arrays.

Authors:  Wenhong Tian; Xiaoyan Dong; Xiaobing Wu; Zhijian Wu
Journal:  Methods Mol Biol       Date:  2013

4.  Role of microRNA-150 in solid tumors.

Authors:  Fang Wang; Xiubao Ren; Xinwei Zhang
Journal:  Oncol Lett       Date:  2015-04-30       Impact factor: 2.967

Review 5.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

6.  An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state.

Authors:  Christos Polytarchou; Dimitrios Iliopoulos; Kevin Struhl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

7.  miR-148 regulates Mitf in melanoma cells.

Authors:  Benedikta S Haflidadóttir; Kristín Bergsteinsdóttir; Christian Praetorius; Eiríkur Steingrímsson
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

Review 8.  Breast cancer epigenetics: from DNA methylation to microRNAs.

Authors:  Jürgen Veeck; Manel Esteller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-01-27       Impact factor: 2.673

9.  Oncoviruses and Pathogenic MicroRNAs in Humans.

Authors:  Yoichi Robertus Fujii
Journal:  Open Virol J       Date:  2009-05-07

10.  Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Authors:  Michael F Gallagher; Richard J Flavin; Salah A Elbaruni; Jamie K McInerney; Paul C Smyth; Yvonne M Salley; Sebastian F Vencken; Sharon A O'Toole; Alexandros Laios; Mathia Yc Lee; Karen Denning; Jinghuan Li; Sinead T Aherne; Kai Q Lao; Cara M Martin; Orla M Sheils; John J O'Leary
Journal:  J Ovarian Res       Date:  2009-12-16       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.